Chronic Inflammatory-Related Disease and Cardiovascular Disease in MESA
Open Access
- 3 March 2025
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 4 (4) , 101640
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (UL1-TR-000040)
- National Heart, Lung, and Blood Institute (UL1-TR-001420)
- National Heart, Lung, and Blood Institute (UL1-TR-001079)
- National Center for Advancing Translational Sciences
This publication has 30 references indexed in Scilit:
- No Standard Risk Factors Is the Marker for Clinical Outcomes in Patients With Myocardial InfarctionJACC: Asia, 2024
- Impact of Cancer, Inflammation, and No Standard Risk Factors in Patients With Myocardial InfarctionJACC: Asia, 2024
- Inflammation and cardiovascular disease: From mechanisms to therapeuticsAmerican Journal of Preventive Cardiology, 2020
- Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular DiseaseJACC, 2016
- Regulation of energy balance by inflammation: Common theme in physiology and pathologyReviews in Endocrine and Metabolic Disorders, 2014
- Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk FactorsThe American Journal of Medicine, 2014
- Dietary patterns are associated with plasma F2-isoprostanes in an observational cohort study of adultsFree Radical Biology and Medicine, 2013
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular DiseaseJACC, 2013
- Making Sense of the Cytokine Storm: A Conceptual Framework for Understanding, Diagnosing, and Treating Hemophagocytic SyndromesPediatric Clinics of North America, 2012
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010